What plan sponsors and brokers need to know about the complex world of specialty drugs: A PBM roadmap

The complex world of specialty drugs and pharmacy benefits management (PBM) presents various challenges while also offering fresh opportunities. Concerns such as patient choice, transparency, and quality of care continue to grow, highlighting the need for enhancements in this essential healthcare sector.

This white paper articulates a thorough strategy for addressing specialty drugs with the objective of boosting patient outcomes, curbing healthcare costs, and enhancing system efficiency. By leveraging data-driven insights and cutting-edge technologies, we address the shortcomings of the existing PBM model, particularly in relation to specialty drugs. Our blueprint advocates for a shift towards a more patient-centric PBM landscape that prioritizes choice, competition, and exceptional care.

Within the paper, you will find specific solutions designed to improve the sector. Our focus lies in fostering a PBM environment that values not only the fiscal interests of managing entities but also the health and wellness of patients. We invite all stakeholders, including healthcare providers, insurers, patients, and policy-makers, to join this crucial conversation about the future of specialty drugs within the PBM space.